Bile Acids and Hepatobiliary Diseases - Basic Research and Clinical Application

Adolf-Windaus-Award 1996; W. Gerok. <strong>Adolf-Windaus-Prize Lecture:</strong> Bile Acid Transport Systems as Pharmaceutical Targets; W. Kramer. <strong>I: Bile</strong> <strong>Acid Biosynthesis and Metabolism.</strong> <strong>1.</strong> Determinants of Biliary Bile Acid Composition in Mammals: Influence of Age and Gender; M. Gavrilkina, et al. <strong>2.</strong> Identification of a Unique Inborn Error in Bile Acid Conjugation Involving a Deficiency in Amidation; K.D.R. Setchell, et al. <strong>3.</strong> Regulation of Sterol 27-Hydroxylase and Its Role in the Regulation of `acidic' Pathway of Bile Acid Synthesis; Z.R. Vlahcevic, et al. <strong>4.</strong> Sterol 12alpha-hydroxylase: a Key Cytochrome P-450 in Bile Acid Synthesis. Cloning and Expression of the Rabbit Enzyme; G. Eggertsen, et al. <strong>5.</strong> Stereochemistry of Peroxisomal Side-Chain Degradation in Bile-Salt Biosynthesis; W. Dieminger, et al. <strong>6.</strong> Does Cisapride Overcome the Effects of Octreotide on Intestinal Transit, Thereby Reducing the Proportion of Deoxycholic Acid in Bile and Serum? M.J. Vesey, et al. <strong>II: Hepatic Bile Acid Transport. 7.</strong> Regulation of Bile Acid Carrier Expression in Normal and Diseased Liver; P.J. Meier. <strong>8.</strong> Regulation of the Organic Anion Transporting Polypeptide of Human Liver; G.A. Kullak-Ublick, et al. <strong>9.</strong> Regulation of Bile Acid Transporters in Experimental Cholestasis; C. Gartung, J.L. Boyer. <strong>10.</strong> Regulation of Hepatocyte Bile Salt Transporters by Endotoxin and Cytokines; R.M. Green, J.L. Gollan. <strong>11.</strong> ATP-Binding Cassette Proteins and the Molecular Basis of Liver Cell Membrane Transport; N. Lomri, et al. <strong>12.</strong> ATP-Dependent Transport of Dianionic Bile Salts by the Canalicular Isoform of the Multidrug Resistance Protein (MRP2/cMRP/cMOAT); D. Keppler, et al. <strong>13.</strong> Cloning and Characterization of cMOAT, a Transporter for Divalent Anionic Bile Salts; C.C. Paulusma, et al. <strong>14.</strong> Stimulation of Bile Acid Secretion by Tauroursodeoxycholate and Cell Swelling Involves Mitogen-Activated Protein Kinase; D. H&auml;ussinger, et al. <strong>III: Intestinal Bile Acid</strong> <strong>Transport.</strong> <strong>15.</strong> The Molecular Genetics of Ileal Bile Acid Transport; P.A. Dawson, P. Oelkers. <strong>16.</strong> Properties and Specificity of the Rabbit Ileal Na⁺/Bile Acid Cotransport System; W. Kramer, et al. <strong>17.</strong> Regulation of the Sodium-Dependent Ileal Bile Acid Transporter in the Rat; R.T. Stravitz, et al. <strong>18.</strong> Effect of Cholestasis on Ileal and Jejunal Absorption of Bile Acids in Rat; P. Sauer, et al. <strong>19.</strong> Cloning and Characterization of a Regulon Involved in Bile Acid Transport and 7-Dehydroxylation in an Intestinal Eubacterium Species; D.H. Mallonee, P.B. Hylemon. <strong>IV: Biological Actions of Bile Acids.</strong> <strong>20.</strong> Effects of Bile Acids on Bile Secretion; J.L. Boyer. <strong>21.</strong> Modulation of Hepatocellular Signaling by Bile Acids; U. Beuers, et al. <strong>22.</strong> Ursodeoxycholate Activates Ca²⁺-dependent Cl^- currents in a Human Biliary Cell Line; R. Roman, et al. <strong>23.</strong> Bile Salt Stimulation of Biliary Phospholipid Secretion; J.M. Crawford. <strong>24.</strong> Organic Anions Do Not Impair Bile Salt Micellization in In Vitro Model Bile Systems: Implications for the Mechanism of Organic Anion-Induced Inhibition of Biliary Lipid Secretion In Vivo; H.J. Verkade, et al. <strong>25.</strong> Antioxidant Properties of Bile Acids Evaluated with Enhanced Chemiluminescent Assay: A Possible Physiological Role; A. Roda, et al. <strong>26.</strong> Bile Salt Induces Alterations in Bilayer Permeability: Insights Into Cytoprotection and Cytotoxicity; A. Albalak, et al. <strong>27.</strong> Effector Proteases in Bile Salt-Induced Hepatocyte Apoptosis; L.R. Roberts, et al. <strong>28.</strong> Borderline Pathology in mdr2(-l-) Rescue Mice: A New Model to Study Non-Suppurative Cholangitis; M. de Vree, et al. <strong>29.</strong> Effects of Deoxycholic Acid on Cholesterol and Bile Acid Metabolism in Human Liver; C. Einarsson, et al. <strong>30.</strong> Bile Acids Modulate the Interferon Signalling Pathway; P. Podevin, et al. <strong>31.</strong> Obstructive Cholestasis Inhibits the Rate of Cholesterol 7&agr;-Hydroxylation in Humans In Vivo; M. Bertolotti, et al. <strong>V: Bile Acids in Therapy.</strong> <strong>32.</strong> Multi-Drug Treatment for Primary Biliary Cirrhosis: Is More Better?; B.J.F. van Hoogstraten, et al. <strong>33.</strong> Ursodeoxycholic Acid in Combination with Prednisolone or Budenoside in the Therapy of Primary Biliary Cirrhosis; U. Leuschner, et al. <strong>34.</strong> Bile Acid Synthesis, Metabolism and Secretion in Primary Biliary Cirrhosis Before and After Steroid and Colchicine Treatment; E. Roda, et al. <strong>35.</strong> Medical Treatment of Primary Sclerosing Cholangitis: On the Role of Ursodeoxycholic Acid; A. Stiehl, et al. <strong>36.</strong> Ursodeoxycholic Acid in the Treatment of Cholestasis of Pregnancy; J. Palma, et al. <strong>37.</strong> Clinical Outcome of Long-Term Treatment of Ursodeoxycholic Acid in Patients with Cystic Fibrosis-Associated Liver Disease; C. Colombo, et al.